These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 12645667)

  • 1. Antibodies against beta-lactamase can improve ceftazidime treatment of lung infection with beta-lactam-resistant Pseudomonas aeruginosa in a rat model of chronic lung infection.
    Ciofu O; Bagge N; Høiby N
    APMIS; 2002 Dec; 110(12):881-91. PubMed ID: 12645667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response.
    Ciofu O
    APMIS Suppl; 2003; (116):1-47. PubMed ID: 14692154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid development in vitro and in vivo of resistance to ceftazidime in biofilm-growing Pseudomonas aeruginosa due to chromosomal beta-lactamase.
    Bagge N; Ciofu O; Skovgaard LT; Høiby N
    APMIS; 2000 Sep; 108(9):589-600. PubMed ID: 11110047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative analysis of the IgG and IgG subclass immune responses to chromosomal Pseudomonas aeruginosa beta-lactamase in serum from patients with cystic fibrosis by western blotting and laser scanning densitometry.
    Petersen TD; Ciofu O; Pressler T; Giwercman B; Pedersen SS; Høiby N
    Thorax; 1996 Jul; 51(7):733-8. PubMed ID: 8882082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies against chromosomal beta-lactamase.
    Giwercman B; Rasmussen JW; Cioufu O; Clemmentsen I; Schumacher H; Høiby N
    Antimicrob Agents Chemother; 1994 Oct; 38(10):2306-10. PubMed ID: 7840561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunization with Pseudomonas aeruginosa vaccines and adjuvant can modulate the type of inflammatory response subsequent to infection.
    Johansen HK; Espersen F; Cryz SJ; Hougen HP; Fomsgaard A; Rygaard J; Høiby N
    Infect Immun; 1994 Aug; 62(8):3146-55. PubMed ID: 8039883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of allotypes on the IgG subclass response to chromosomal beta-lactamase of Pseudomonas aeruginosa in cystic fibrosis patients.
    Ciofu O; Pressler T; Pandey JP; Høiby N
    Clin Exp Immunol; 1997 Apr; 108(1):88-94. PubMed ID: 9097916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies against Pseudomonas aeruginosa chromosomal beta-lactamase inpatients with cystic fibrosis are markers of the development of resistance of P. aeruginosa to beta-lactams.
    Ciofu O; Giwercman B; Walter-Rasmussen J; Pressler T; Pedersen SS; Høiby N
    J Antimicrob Chemother; 1995 Feb; 35(2):295-304. PubMed ID: 7759393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-exposure immunization by capsid-modified AdC7 vector expressing Pseudomonas aeruginosa OprF clears P. aeruginosa respiratory infection.
    Gomi R; Sharma A; Wu W; Sung B; Worgall S
    Vaccine; 2017 Dec; 35(51):7174-7180. PubMed ID: 29126807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High β-lactamase levels change the pharmacodynamics of β-lactam antibiotics in Pseudomonas aeruginosa biofilms.
    Hengzhuang W; Ciofu O; Yang L; Wu H; Song Z; Oliver A; Høiby N
    Antimicrob Agents Chemother; 2013 Jan; 57(1):196-204. PubMed ID: 23089750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Avidity of anti-P aeruginosa antibodies during chronic infection in patients with cystic fibrosis.
    Ciofu O; Petersen TD; Jensen P; Høiby N
    Thorax; 1999 Feb; 54(2):141-4. PubMed ID: 10325919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of ginseng treatment on neutrophil chemiluminescence and immunoglobulin G subclasses in a rat model of chronic Pseudomonas aeruginosa pneumonia.
    Song Z; Kharazmi A; Wu H; Faber V; Moser C; Krogh HK; Rygaard J; Hoiby N
    Clin Diagn Lab Immunol; 1998 Nov; 5(6):882-7. PubMed ID: 9801351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of antibiotic resistance in Pseudomonas aeruginosa during two decades of antipseudomonal treatment at the Danish CF Center.
    Ciofu O; Giwercman B; Pedersen SS; Høiby N
    APMIS; 1994 Sep; 102(9):674-80. PubMed ID: 7946270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental chronic Pseudomonas aeruginosa lung infection in rats. Non-specific stimulation with LPS reduces lethality as efficiently as specific immunization.
    Lange KH; Hougen HP; Høiby N; Fomsgaard A; Rygaard J; Johansen HK
    APMIS; 1995 May; 103(5):367-74. PubMed ID: 7654361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pseudomonas aeruginosa-specific IgG1 and IgG2 subclasses in enhancement of pulmonary clearance following passive immunisation in the rat.
    Dunkley ML; Rajyaguru S; McCue A; Cripps AW; Kyd JM
    FEMS Immunol Med Microbiol; 2003 Oct; 39(1):37-44. PubMed ID: 14556994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Qiguiyin Decoction on multidrug-resistant Pseudomonas aeruginosa infection in rats.
    Kong LB; Ma Q; Gao J; Qiu GS; Wang LX; Zhao SM; Bao YG; Liu QQ
    Chin J Integr Med; 2015 Dec; 21(12):916-21. PubMed ID: 26424290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of experimental pneumonia in rats caused by a PER-1 extended-spectrum beta-lactamase-producing strain of Pseudomonas aeruginosa.
    Mimoz O; Elhelali N; Léotard S; Jacolot A; Laurent F; Samii K; Petitjean O; Nordmann P
    J Antimicrob Chemother; 1999 Jul; 44(1):91-7. PubMed ID: 10459815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial Activity of Ceftazidime-Avibactam against Gram-Negative Bacteria Isolated from Patients Hospitalized with Pneumonia in U.S. Medical Centers, 2011 to 2015.
    Sader HS; Castanheira M; Flamm RK
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28069649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of Ceftolozane-Tazobactam against Pseudomonas aeruginosa and Enterobacteriaceae Isolates Collected from Respiratory Tract Specimens of Hospitalized Patients in the United States during 2013 to 2015.
    Castanheira M; Duncan LR; Mendes RE; Sader HS; Shortridge D
    Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29263073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution of Pseudomonas-Derived Cephalosporinase and Metallo-β-Lactamases in Carbapenem-Resistant Pseudomonas aeruginosa Isolates from Korea.
    Cho HH; Kwon GC; Kim S; Koo SH
    J Microbiol Biotechnol; 2015 Jul; 25(7):1154-62. PubMed ID: 25907063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.